Cargando…
Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy
Iron-overload cardiomyopathy is prevalent on a worldwide basis and is a major comorbidity in patients with genetic hemochromatosis and secondary iron overload. Therapies are limited in part due to lack of a valid preclinical model, which recapitulates advanced iron-overload cardiomyopathy. Male hemo...
Autores principales: | Das, Subhash K., Zhabyeyev, Pavel, Basu, Ratnadeep, Patel, Vaibhav B., Dyck, Jason R.B., Kassiri, Zamaneh, Oudit, Gavin Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435471/ https://www.ncbi.nlm.nih.gov/pubmed/29208771 http://dx.doi.org/10.1042/BSR20171302 |
Ejemplares similares
-
Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy
por: Das, Subhash K., et al.
Publicado: (2015) -
Females Are Protected From Iron‐Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress
por: Das, Subhash K., et al.
Publicado: (2017) -
Amlodipine rescues advanced iron overload cardiomyopathy in hemojuvelin knockout murine model: Clinical implications
por: Zhabyeyev, Pavel, et al.
Publicado: (2023) -
Loss of Apelin Exacerbates Myocardial Infarction Adverse Remodeling and Ischemia‐reperfusion Injury: Therapeutic Potential of Synthetic Apelin Analogues
por: Wang, Wang, et al.
Publicado: (2013) -
PI3Kα Pathway Inhibition With Doxorubicin Treatment Results in Distinct Biventricular Atrophy and Remodeling With Right Ventricular Dysfunction
por: McLean, Brent A., et al.
Publicado: (2019)